Cargando…
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Efficacy of candidate antibacterial treatments must be demonstrated in animal models of infection as part of the discovery and development process, preferably in models which mimic the intended clinical indication. A method for inducing robust lung infections in immunocompetent rats and mice is desc...
Autores principales: | Hoover, Jennifer L., Lewandowski, Thomas F., Mininger, Cindy L., Singley, Christine M., Sucoloski, Scott, Rittenhouse, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MyJove Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408714/ https://www.ncbi.nlm.nih.gov/pubmed/28117818 http://dx.doi.org/10.3791/55068 |
Ejemplares similares
-
Reducing Antibacterial Development Risk for GSK1322322 by Exploring Potential Human Dose Regimens in Nonclinical Efficacy Studies Using Immunocompetent Rats
por: Hoover, Jennifer L., et al.
Publicado: (2017) -
1560. Pharmacokinetics–Pharmacodynamics (PK-PD) of Gepotidacin (GEP) Against Escherichia coli in Murine Pyelonephritis and Thigh Infection Models
por: Barth, Aline, et al.
Publicado: (2019) -
A COMPARISON OF THE INCIDENCE OF VENTILATOR-ASSOCIATED PNEUMONIA AMONG PATIENTS WITH COVID-19 AND INFLUENZA PNEUMONIA A AND B
por: GROSSMAN, J., et al.
Publicado: (2022) -
SERRATIA MARCESCENS CAVITARY PNEUMONIA FOLLOWING COVID-19 INFECTION IN A YOUNG IMMUNOCOMPETENT HOST
por: WALTERS, LAURA, et al.
Publicado: (2022) -
Involvement of HisF in the Persistence of Acinetobacter baumannii During a Pneumonia Infection
por: Martínez-Guitián, Marta, et al.
Publicado: (2019)